Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) Shunt

Launched by DAVINCI LTD · Nov 14, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the long-term safety and effectiveness of a special device called a modified suprachoroidal silicone tube (SST) shunt for people with certain types of glaucoma, including primary open-angle glaucoma and pseudo-exfoliative glaucoma. The main goals are to see if this shunt can help lower eye pressure over time and to check how it affects the health of the cornea, which is the clear front part of the eye.

To participate in this study, individuals should have previously received treatment with the SST shunt and be willing to return for follow-up visits. During these visits, participants will have their eye pressure measured, their vision assessed, and checks will be made on the health of the cells in their cornea. The study is currently looking for participants of all ages, and it’s important that they can provide informed consent and attend follow-up appointments. Overall, this trial aims to gather valuable information that could help improve glaucoma treatment and patient outcomes in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Previously were treated with Suprachoroidal silicone tube shunt
• • Willing and able to participate in this cross sectional observational follow up
• • Participant capable of giving informed consent
• Exclusion Criteria:
• • Condition that could impact the ability of the participant to attend a follow-up visit as per the discretion of the investigator